5 global biosimilars of major oncology & immunology biologics by 2020 planned by@Sandoz_Global https://t.co/v9KgiYhmiO @PharmaTimes
5 global biosimilars of major oncology & immunology biologics by 2020 planned by@Sandoz_Global https://t.co/v9KgiYhmiO @PharmaTimes